Epic Biotech 8

For one day, on June 15, 2011, upwards of 60 European biotech companies will present their latest breakthroughs and strategies for the future to the European investment community. The presentations at Epic 8 will revolve around the enhancement of therapies for a wide variety of ailments still plaguing humanity around the world. Presenters will cover areas such as oncology, tissue regeneration, vaccines, immunology, infection and more. These companies are in search of investment, partners or other services that will enable them to carry their highly sought-after products to markets all over the world, beginning with Europe. Epic 8 will take place at the Royal College of Physicians Conference Center in London.

BioTrinity 2011

Europe’s fastest growing biopartnering and investment conference is scheduled for April 12-14, 2011 at Newbury Racecourse in the UK. 60 presentations are on tap, each from an R&D company specially selected for this conference. All R&D companies participating feature products, which could be on the market helping people in a matter of a few years, depending on clinical trial outcomes. In 2010, BioTrinity featured 62 investment firms from 10 countries, and that number is set to increase to 75 in 2011. If a company is among the top 20 pharma firms in the world, it will likely be at BioTrinity 2011. In fact, the conference is proud to host Europe’s largest investor-only dinner.

Bio CEO

The 13th annual Bio CEO investment conference will be held February 14-15, 2011, at the beautiful WaldorfAstoria in New York City. Bio CEO is a Mecca for both established and emerging public biotech companies from around the world. Indeed, Bio CEO is the largest conference strictly for investors and publicly traded biotech companies. At Bio CEO, investors can look forward to unbiased presentations  given within the broader context of world biotech. Participants will have unique opportunities to learn from CSOs, MDs and industry analysts about the latest therapeutic trends and the companies taking advantage of them. The 2011 conference is set to be one of the largest yet, with 95 companies already confirmed to pitch their unique therapies to an audience of some of the premier investment firms in the world today.

BioBusiness 2011

BioBusiness is a more intimate biotech conference, allowing biotech companies, partners and investors to have candid discussions of how biotech will shape the 21st century. Biotech firms from around the world will have the opportunity to network and pitch to investors in a setting, which allows for plenty of Q&A following each presentation and abundant side-seminars, in which companies present the latest in bio therapies. This year’s conference will be focused on innovations in a down economy, with the understanding that breakthroughs are occurring every day, even in this cost-cutting environment. Each company is looking to find a partner that can help them bring their unique products to market so that when the recession abates, they have a powerful claim to the elite of biotech.

Biotech Showcase 2011

This fast-growing biotech investment conference has just been moved to a larger location. It will take place January 10-12, 2011 at the Park 55 Hotel in San Francisco, California. Biotech Showcase is the place where biotech startups can mingle with both public and private investors eager to help winning companies get their cutting-edge therapies to market. In 2011, over 150 public and private companies are scheduled to present to at least 800 attendees, a 10% increase from 2010. This growth highlights the vibrancy of this sector and portends even more rapid growth in the future. In addition to standard presentations, Bio Tech Showcase offers a rich assortment of workshops and seminars to educate participants on current therapeutic breakthroughs and future possibilities.